Long-Term Liabilities to Equity: clearpointneuro.com (CLPT)

This daily price chart for ClearPoint Neuro, Inc. (CLPT) reflects the performance of the neuronavigation systems developer, where the indicator stands at 5.68. Active expansion into new clinics establishes a foundation for growth, although R&D expenses continue to weigh on earnings. Steady cash flow is driven by services and the sale of components, while efficient management of optics supply chains ensures high production profitability.

This ratio determines the relationship between long-term liabilities and equity, measuring financial leverage and the company's degree of dependence on external borrowing. The stable workforce of engineers and specialists at ClearPoint Neuro (CLPT) reduces operational risks, making the long-term debt-to-equity structure a key indicator of the business's ability to scale neurosurgical systems without the threat of bankruptcy.